United States · FDA National Drug Code directory
Risperidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59746-225_39d41b28-93eb-446b-9652-7432858ccbab
- Product NDC
- 59746-225
- Form
- TABLET
- Composition / generic term
- Risperidone
- Labeler
- Jubilant Cadista Pharmacuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251015
- Source listing expiry
- 20261231
Source-listed ingredients
- RISPERIDONE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (59746-225-05) · 59746-225-05
- 60 TABLET in 1 BOTTLE (59746-225-60) · 59746-225-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →